Credit Suisse S&P ETFs Autocallable Notes Investor Lawsuits

Credit Suisse S&P ETFs Autocallable Notes Results in Potential Significant Investor Risk

The White Law Group is investigating potential securities lawsuits involving Credit Suisse S&P ETFs Autocallable Notes.

Investors who purchased a structured product from Credit Suisse linked to the worst-performing of three ETFs—SPDR® S&P® Bank ETF, SPDR® S&P® Biotech ETF, and the Technology Select Sector SPDR® Fund—may face significant downside risk.

The structured note in question—Credit Suisse’s Contingent Coupon Autocallable Yield Notes (CUSIP: 22552X4W0)—was issued in January 2021 with a face value of $3,116,000. The note’s performance is based on the lowest-performing ETF, exposing investors to high downside potential.

Details of the Investment – Credit Suisse S&P ETFs

• Product Type: Contingent Coupon Autocallable Yield Note
  
• Face Value: $3,116,000
  
• Final Payout: Based on the worst-performing ETF on October 28, 2022
  
• If all ETFs ? Coupon Barrier (75% of initial): $1,000 + $36.625 coupon per note
  
• If worst ETF < Trigger Level (60% of initial): $1,000 × (final value ÷ initial value) — possible full loss
  
• Total Loss Potential: Up to 100% of principal based on performance of the lowest ETF
• SPDR® S&P® Bank ETF (NYSEARCA: KBE)
  
• SPDR® S&P® Biotech ETF (NYSEARCA: XBI)
  
• Technology Select Sector SPDR® Fund (NYSEARCA: XLK)

Why Could the Investment Lose Value?

Multi-asset autocallables are complex and expose investors to the weakest link. In this case:

• Note is automatically called if all ETFs exceed initial level on an observation date
  
• If not called and worst ETF is below the trigger, payout is significantly reduced
  
• No coupon paid if any ETF is below the coupon barrier
  
• Estimated value at issuance: $982.75 per $1,000 note

Understanding the Risks Credit Suisse S&P ETFs

Despite high contingent coupon potential, risks include:

• Market risk of all three underlying ETFs
  
• Exposure to worst-performing ETF
  
• Credit risk of Credit Suisse AG
  
• Possibility of no income and capital loss
  
• Not FDIC insured or government guaranteed

Did Your Financial Advisor Recommend This Investment?

If this multi-ETF autocallable product was misrepresented or unsuitable based on your financial profile, you may be eligible to recover losses through FINRA arbitration.

FINRA Arbitration vs. Class Action

• FINRA arbitration better addresses large individual losses
  
• Class actions apply to smaller, uniform investor claims

Free Consultation

The White Law Group is investigating potential claims involving Credit Suisse S&P ETFs Autocallable Notes. If you have suffered losses, call (888) 637-5510 for a free consultation.

Visit www.whitesecuritieslaw.com for more information on active investigations.